The largest database of trusted experimental protocols

Ki 67 primary antibodies

Manufactured by Abcam
Sourced in United States

Ki-67 primary antibodies are used to detect the Ki-67 protein, which is a cellular marker for proliferation. The Ki-67 protein is expressed during all active phases of the cell cycle (G1, S, G2, and mitosis), but is absent in resting cells (G0). This makes Ki-67 a useful tool for determining the growth fraction of a given cell population.

Automatically generated - may contain errors

2 protocols using ki 67 primary antibodies

1

Evaluating PAEC Proliferation via Ki-67

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ki-67 immunofluorescence staining was performed using the labeled streptavidin–biotin method to evaluate the proliferation of PAECs. After being washed three times with phosphate buffer saline (PBS), the PAECs were sequentially fixed in 4% paraformaldehyde at 4°C for 20 min, permeabilized with 0.2% Triton X-100 in PBS for 5 min, and blocked with 3% bovine serum albumin in PBS for 1 h at room temperature. The cells were then incubated with the Ki-67 primary antibodies (1:500 dilution, Abcam, Cambridge, MA, United States) at 4°C overnight, and then stained with goat anti-rabbit IgG antibody (1:500, Thermo Fisher Scientific, Alexa Fluor 488) at 37°C for 1 h. Finally, nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI; 1:500, Abcam). The Ki-67 immunostaining of PAECs were detected by a fluorescence microscope (Zeiss, Heidenheim, Germany). The percentage of Ki-67-positive cells was indicated as the proliferation rate of PAECs. Measurements were repeated three times.
+ Open protocol
+ Expand
2

Immunohistochemistry Protocol for CD13 and Ki-67

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed on 5 μm thick formalin-fixed paraffin embedded sections using the Discovery XT and Discovery Ultra research instruments (Ventana Medical Systems, Inc. Tucson, Arizona, USA). Sections were deparaffinized with Discovery EZ prep and then either heat retrieved with the proprietary solutions, Discovery RiboCC and Discovery CC1, or pretreated with Protease 2 (Ventana Medical Systems, Inc. Tucson, Arizona, USA) at 37˚C. Sections were then incubated with either CD13 or Ki-67 primary antibodies (abcam, Cambridge, Massachusetts, USA). The concentrations, temperature and incubation times were based on protocols optimized with positive control tissues. A systematic protocol for each antibody is listed in supplementary Tables 1 and 2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!